Charles M. Baum
Impact in
- Gastroenterology top 0.1%
- Gastrointestinal Tumor Research and Treatment
- Pulmonary and Respiratory Medicine top 0.1%
- Renal cell carcinoma treatment
- Gastric Cancer Management and Outcomes
- Sarcoma Diagnosis and Treatment
Papers in
-
- Gastrointestinal Tumor Research and Treatment 28
- Hematology 24
- Platelet Disorders and Treatments 16
- Chronic Myeloid Leukemia Treatments 8
- Hematopoietic Stem Cell Transplantation 5
- Co-authors
- M. Dror MichaelsonRobert J. MotzerSindy T. KimRobert A. FiglinRonald M. BukowskiThomas E. HutsonPiotr TomczakOlivier Rixe
- Journals
- Journal of Clinical Oncology (39 papers)Clinical Cancer Research (4 papers)Cardiovascular Therapeutics (2 papers)The Journal of Experimental Medicine (2 papers)Experimental Hematology (2 papers)
- Partner nations
- United StatesAustraliaGermany
In The Last Decade
Charles M. Baum
70 papers receiving 12.4k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Gastroenterology 2.2k
- Pulmonary and Respiratory Medicine 8.2k
- Cancer Research 3.4k
- Oncology 4.7k
- Molecular Biology 5.9k
Countries citing papers authored by Charles M. Baum
This map shows the geographic impact of Charles M. Baum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles M. Baum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles M. Baum more than expected).
Fields of papers citing papers by Charles M. Baum
This network shows the impact of papers produced by Charles M. Baum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles M. Baum. The network helps show where Charles M. Baum may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Charles M. Baum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 15 | |
| 2 | 2017 | 14 | |
| 3 | 2009 | 38 | |
| 4 | 2009 | 104 | |
| 5 | Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor Hit paper breakdown → | 2008 | 564 |
| 6 | 2008 | 162 | |
| 7 | 2008 | 14 | |
| 8 | Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma Hit paper breakdown → | 2007 | 4471 |
| 9 | Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial Hit paper breakdown → | 2006 | 1930 |
| 10 | Sunitinib in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2006 | 969 |
| 11 | Activity of SU11248, a Multitargeted Inhibitor of Vascular Endothelial Growth Factor Receptor and Platelet-Derived Growth Factor Receptor, in Patients With Metastatic Renal Cell Carcinoma Hit paper breakdown → | 2005 | 1304 |
| 12 | 2003 | 22 | |
| 13 | 2003 | 30 | |
| 14 | 2002 | 89 | |
| 15 | 2002 | 10 | |
| 16 | 2000 | 18 | |
| 17 | 2000 | 3 | |
| 18 | 2000 | 14 | |
| 19 | 1993 | 1 | |
| 20 | 1991 | 137 |
About Charles M. Baum
Charles M. Baum is a scholar working on Gastroenterology, Hematology, Pulmonary and Respiratory Medicine, Cancer Research and Oncology, having authored 71 papers that have together received 12.8k indexed citations. Recurring topics across this work include Gastrointestinal Tumor Research and Treatment (28 papers), Renal cell carcinoma treatment (18 papers), Platelet Disorders and Treatments (16 papers), Cancer Genomics and Diagnostics (12 papers), Sarcoma Diagnosis and Treatment (10 papers), Gastric Cancer Management and Outcomes (9 papers), Chronic Myeloid Leukemia Treatments (8 papers) and Hematopoietic Stem Cell Transplantation (5 papers). The work is most often cited by research in Gastroenterology (2.2k citations), Pulmonary and Respiratory Medicine (8.2k citations), Cancer Research (3.4k citations), Oncology (4.7k citations) and Molecular Biology (5.9k citations). Charles M. Baum has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include M. Dror Michaelson, Robert J. Motzer, Sindy T. Kim, Robert A. Figlin, Ronald M. Bukowski, Thomas E. Hutson, Piotr Tomczak, Olivier Rixe, Stéphane Oudard and Paul Bycott. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research, Cardiovascular Therapeutics, The Journal of Experimental Medicine and Experimental Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.